Skip to main content
Clinical Trials/ACTRN12619001590156
ACTRN12619001590156Recruiting未知

Analysis of brain natriuretic peptide levels in patients with atrial fibrillation undergoing atrioventricular node ablation

Princess Alexandra Hospital0 sites30 target enrollmentStarted: November 19, 2019Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
All

Inclusion Criteria

  • oAge greater than or equal to 18 years
  • oPermanent atrial fibrillation
  • oLeft ventricular ejection fraction (LVEF) >45%
  • oClinical indication for AV node ablation
  • oPermanent pacemaker already implanted or planned to be implanted prior to AV node ablation
  • oAble to provide written informed consent

Exclusion Criteria

  • oAge < 18 years
  • oInability to provide consent
  • oLVEF <45% or decompensated heart failure
  • oSevere valvular lesions

Investigators

Similar Trials

Analysis of brain natriuretic peptide... | Clinical Trial